Answers are grounded in this paper and cite their sources.
Alcohol use disorder (AUD) is accompanied by persistent neuroadaptations, among which DNA methylation represents a mechanistically tractable, long-lasting epigenetic layer. Synthesizing evidence from human, non-human primate, and rodent studies alongside multi-omic datasets, this review establishes a cross-level framework of alcohol-induced 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) dysregulation across the three-stage addiction cycle. Chronic alcohol disrupts central one-carbon metabolism by lowering the SAM:SAH methylation index and impairing TET-dependent hydroxymethylation, producing a near-global hypomethylated backdrop with region-specific variations that coexists with locus-specific hypermethylation at plasticity genes. We map this dichotomy across five core circuit nodes (prefrontal cortex, nucleus accumbens, dorsal striatum, cerebellum, and amygdala), linking distinct 5mC and 5hmC signatures to executive failure, compulsive seeking, habit formation, loss of tonic inhibition, and negative reinforcement. Finally, to overcome key field challenges, including cellular heterogeneity, causal ambiguity versus exposure “scars”, and 5mC/5hmC array conflation, we evaluate single-nucleus multi-omics, CRISPR epigenome editing, methyl-donor interventions, and pharmacoepigenetics as translational axes toward precision medicine in AUD.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: